PRKDC and gastric cancer: LncLEMGC interacts with DNA-PKcs and inhibits the phosphorylation of DNA-PKcs at Ser2056, ultimately inhibiting the progression and metastasis of gastric cancer by downregulating the ErbB1-SRC-FAK signaling pathway [69].